Back to search

Article

Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for Immunomodulation

2025-07-22

Abstract excerpt

<h4>ABSTRACT</h4> Mesenchymal stromal cells (MSCs) are widely studied for their immunomodulatory and tissue reparative capabilities, but clinical translation has been hampered by inconsistent efficacy and limited standardization in manufacturing. While cytokine-based priming methods, such as interferon-gamma (IFN-γ) stimulation, have shown promise in enhancing MSC potency, alternative approaches targeting distinc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1c399515-d1e3-5ee6-a363-1623425db8fa
DOI
10.1101/2025.07.17.665406
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Sphingomyelinase Licensing of Mesenchymal Stromal Cells Alters Lipid and Protein Metabolites for ImmunomodulationDOI 10.1101/2025.07.17.665406
Select a neighboring publication to make it the new centre.